Reaction

Liver Transplant reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,575 reports · 78 co-occurring drugs

As of the last recalculation, Liver Transplant appears in 3,575 FAERS reports alongside 78 co-occurring drug terms. The strongest observed disproportionality signal is RIFAXIMIN (PRR 47.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Rifaximin	164	47.7	48.1
Sofosbuvir	133	40.7	41.0
Tenofovir Disoproxil Fumarate Tablets	40	27.3	27.4
Ursosiol	82	25.1	25.2
Ursodiol	83	22.7	22.8
Epoprostenol	45	20.3	20.3
Entecavir	38	19.1	19.2
Pyrazinamide	27	16.9	16.9
Ribavirin	174	16.5	16.6
Velpatasvir And Sofosbuvir	31	14.2	14.2
Isoniazid	39	14.2	14.2
Rifampin	35	14.1	14.1
Valganciclovir	45	14.1	14.1
Valganciclovir Hydrochloride	45	14.1	14.1
Tolvaptan	33	13.3	13.4
Macitentan	143	12.5	12.5
Phytonadione	18	12.4	12.4
Tacrolimus	284	11.4	11.4
Ledipasvir And Sofosbuvir	37	11.3	11.3
Glecaprevir And Pibrentasvir	20	10.7	10.7
Basiliximab	21	10.5	10.5
Selexipag	45	10.3	10.3
Tenofovir Disoproxil Fumarate	56	10.0	10.0
Valganciclovir Hydrochloride Powder,	20	9.6	9.6
Lamivudine	50	9.5	9.6
Rifampicin	16	9.2	9.3
Abacavir Sulfate	15	9.0	9.0
Raltegravir	25	8.9	8.9
Lactulose	56	8.6	8.6
Sildenafil Powder,	51	8.4	8.5
Zidovudine	19	8.3	8.3
Sildenafil	80	8.2	8.2
Efavirenz	15	7.9	7.9
Tacrolimus Ointment 0.1%	155	7.5	7.5
Tacrolimus Extended-Release Capsules	155	7.5	7.5
Lamivudine Oral	32	7.4	7.4
Ambrisentan	150	7.3	7.3
Tadalafil	111	6.6	6.6
Mycophenolic Acid	36	6.6	6.6
Ganciclovir	11	6.3	6.3
Ganciclovir Sodium	11	6.1	6.1
Busulfan	16	5.9	5.9
Ivacaftor	8	5.9	5.9
Dolutegravir Sodium	9	5.8	5.8
Mycophenilic Acid	20	5.6	5.6
Elexacaftor, Tezacaftor, And Ivacaftor	12	5.6	5.6
Sildenafil Citrate	116	5.4	5.5
Mycophenolate Mofetil	114	5.0	5.0
Mycophenolate Mofetil Hydrochloride	114	5.0	5.0
Acetylcysteine	8	5.0	5.0
Sulfamethoxazole And Trimethoprim	70	4.9	4.9
Erythropoietin	17	4.8	4.8
Nitrofurantoin	13	4.6	4.6
Cyclosporine	86	4.6	4.6
Nitrofurantoin (Monohydrate/Macrocrystals)	13	4.5	4.5
Treprostinil	94	4.5	4.5
Peginterferon Alfa-2A	40	4.3	4.3
Lumacaftor And Ivacaftor	6	4.1	4.1
Tafamidis	8	4.0	4.0
Sirolimus	9	3.9	3.9
Atovaquone	5	3.6	3.6
Bosentan	31	3.6	3.6
Riociguat	20	3.6	3.6
Dornase Alfa	12	3.6	3.6
Ritonavir 100 Mg	9	3.5	3.5
Patiromer	8	3.4	3.4
Pancrelipase	22	3.3	3.3
Risankizumab-Rzaa	46	3.3	3.3
Emtricitabine And Tenofovir Disoproxil Fumarate	22	2.8	2.8
Sorafenib	10	2.8	2.8
Vedolizumab	36	2.4	2.4
Romiplostim	6	2.3	2.3
Orlistat	10	2.3	2.3
Ranolazine	4	2.2	2.2
Emtricitabine And Tenofovir Alafenamide	4	2.1	2.1
Guselkumab	11	1.8	1.8
Ethyl Alcohol	8	1.7	1.7
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	5	1.6	1.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.